[1]MALHI H,GORES GJ.Review article:the modern diagnosis and therapy of cholangioearcinoma[J].Aliment Pharmacol Ther,2006,23(9):1287-1296.
|
[2]CHAPMAN R,FEVERY J,KALLOO A,et al.Diagnosis and management of primary sclerosing cholangitis[J].Hepatology,2010,51(2):660-678.
|
[3]CHALASANIC N,BALUYUT A,ISMAIL A,et al.Cholangiocarcinoma in patients with primary sclerosing cholangitis:a multicenter case control study[J].Hepatology,2000,31(1):7-11.
|
[4]JEMAL A,SIEGEL R,WARD E,et al.Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96.
|
[5]Chinese Chapter of International Hepato-Pancreato-Biliary Association,Hepatic Sugery Group,Chinese Society of Surgery,Chinese Medical Association.Diagnosis and treatment of cholangiocarcinoma:sugical expert consensus[J].J Clin Hepatol,2015,31(1):12-16.(in Chinese)国际肝胆胰学会中国分会,中华医学会外科学分会肝脏外科学组.胆管癌诊断与治疗——外科专家共识[J].临床肝胆病杂志,2015,31(1):12-16.
|
[6]LIU MZ,LI H,ZHANG W.Eougebinuc research progress on pathological mechanisms of intrahepatic cholangiocarcinoma[J].Chin J Clin Pharmacd Ther,2014,19(11):1294-1298.(in Chinese)刘谋泽,李浩,张伟.肝内肝管癌病理机制表观基因组学研究进展[J].中国临床药理学与治疗学,2014,19(11):1294-1298.
|